References
1. Gominet M, Compain F, Beloin C, Lebeaux D. Central venous catheters and biofilms: where do we stand in 2017? APMIS . 2017;125(4):365-375. doi:10.1111/apm.12665
2. Cabrini L, Pappacena S, Mattioli L, et al. Administration of blood products to prevent bleeding complications associated with central venous catheter insertion in patients at risk: a systematic review.Br J Anaesth . 2017;118(4):630-634. doi:10.1093/bja/aex060
3. Estcourt LJ, Desborough M, Hopewell S, Doree C, Stanworth SJ. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. Cochrane Haematological Malignancies Group, ed. Cochrane Database Syst Rev . Published online December 2, 2015. doi:10.1002/14651858.CD011771.pub2
4. Study collaborative, van de Weerdt EK, Biemond BJ, et al. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial. Trials . 2018;19(1):127. doi:10.1186/s13063-018-2480-3
5. Agarwal RK, Sedai A, Dhimal S, et al. A prospective international cooperative information technology platform built using open-source tools for improving the access to and safety of bone marrow transplantation in low- and middle-income countries. J Am Med Inform Assoc . 2014;21(6):1125-1128. doi:10.1136/amiajnl-2013-002594
6. Sandeep, Priya G, Prasad S, et al. Patterns of central line infections in two bone marrow transplant units in India among children undergoing allogeneic transplant for thalassaemia. Pediatr Hematol Oncol J . 2018;3(3):S56. doi:10.1016/j.phoj.2018.11.161
7. Stecker MS, Johnson MS, Ying J, et al. Time to Hemostasis after Traction Removal of Tunneled Cuffed Central Venous Catheters. J Vasc Interv Radiol . 2007;18(10):1232-1239. doi:10.1016/j.jvir.2007.06.035
8. Rodriguez D, Park BJ, Almirante B, et al. Impact of early central venous catheter removal on outcome in patients with candidaemia.Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis . 2007;13(8):788-793. doi:10.1111/j.1469-0691.2007.01758.x
9. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis . 2011;52(9):e162-e193. doi:10.1093/cid/cir257
10. Gahlot R, Nigam C, Kumar V, Yadav G, Anupurba S. Catheter-related bloodstream infections. Int J Crit Illn Inj Sci . 2014;4(2):162-167. doi:10.4103/2229-5151.134184
11. Soufir L, Timsit J-F, Mahe C, Carlet J, Regnier B, Chevret S. Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort Study.Infect Control Hosp Epidemiol . 1999;20(6):396-401. doi:10.1086/501639
12. Lebeaux D, Chauhan A, Létoffé S, et al. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. J Infect Dis . 2014;210(9):1357-1366. doi:10.1093/infdis/jiu286
13. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer . 1995;75(6):1367-1375. doi:10.1002/1097-0142(19950315)75:6<1367::aid-cncr2820750620>3.0.co;2-z
14. Molton JS, Tambyah PA, Ang BSP, Ling ML, Fisher DA. The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia. Weinstein RA, ed. Clin Infect Dis . 2013;56(9):1310-1318. doi:10.1093/cid/cit020